Sponsor

Centro Cardiologico Monzino

Clinical research sponsor

Published trials26
Recruiting shown4
Roles2
SourceClinicalTrials.gov

Clinical trials

26 shown
The Effects of Body Scan on Enteroception in Patients With Heart FailureNCT06737679 · lead sponsor · 2025-01-28
RECRUITING
Metabolic Exercise Test Data Combined with Cardiac and Kidney Indexes (MECKI) Score Evolution: Identification of Cardiovascular Risk in Patients with Heart FailureNCT06884631 · lead sponsor · 2021-02-10
RECRUITING
Validation of the Italian SCHFI v.8 and the CC-SCHFI v.3NCT07608393 · lead sponsor · 2026-05-01
NOT_YET_RECRUITING
Artificial Intelligence and Smart Wearable Technologies for Early Detection of Acute Heart FailureNCT05591443 · lead sponsor · 2023-05-01
UNKNOWN
A Dynamic Evaluation of Chronic Heart Failure Prognosis: the MECKI ScoreNCT06070519 · lead sponsor · 2023-05-01
UNKNOWN
Italian Digital Primary Cardiovascular Prevention StudyNCT05339841 · lead sponsor · 2022-06-10
ACTIVE_NOT_RECRUITING
Effects of Dapagliflozin on Cardiorespiratory Parameters in Heart FailureNCT05770167 · lead sponsor · 2022-05-06
UNKNOWN
Coronary Artery Calcium and Cardiovascular Risk Factors Analysis After RT or Breast CancerNCT05775822 · lead sponsor · 2022-03-24
COMPLETED
Cardiovascular Risk Assessment in a Cohort of Italian Patients With Type 1 Diabetes Mellitus (CARDT1)NCT06290544 · lead sponsor · 2021-11-29
UNKNOWN
Effect of the Use of Protective Masks on the Ability to Perform Daily Activities in Patients with Heart Failure or Obstructive Pulmonary DiseaseNCT05762406 · lead sponsor · 2021-06-16
COMPLETED
Furosemide-induced Diuresis With Matched Dehydration Compared to Standard Diuretic Therapy in Patients With Acute Heart Failure and Overt Fluid OverloadNCT05807152 · lead sponsor · 2019-02-19
UNKNOWN
Effects of Sacubitril/Valsartan on Exercise Capacity, Natriuretic Peptides and Ventricular Remodeling in Heart FailureNCT04434170 · lead sponsor · 2018-10-15
COMPLETED
NIRS and DO2i CorrelationNCT03281707 · lead sponsor · 2017-09-30
UNKNOWN
Surfactant Derived Protocol in Heart FailureNCT06896461 · lead sponsor · 2016-05-06
COMPLETED
Indacaterol in Heart Failure Patients: Any Role on Lung Fluid RegulationNCT02598505 · lead sponsor · 2015-09-01
COMPLETED
ProSALUTE: Community Program for Cardiovascular HealthNCT03129165 · lead sponsor · 2015-05-11
UNKNOWN
Dead Space Evaluation in Pulmonary HypertensionNCT02892981 · lead sponsor · 2015-01-01
COMPLETED
Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)NCT02261948 · lead sponsor · 2012-09-01
COMPLETED
Nebivolol Versus Bisoprolol Versus Carvedilol in Heart FailureNCT00517725 · lead sponsor · 2007-07-01
COMPLETED
Effects of Acetazolamide and CO2 Inhalation on Exercise-induced Periodic Breathing in Heart FailureNCT00517426 · lead sponsor · 2007-07-01
COMPLETED
Treatment of Severe Heart Failure by UltrafiltrationNCT00360958 · lead sponsor · 2006-08-01
COMPLETED
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)NCT06311708 · collaborator · 2023-01-31
RECRUITING
Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of ImagingNCT05081115 · collaborator · 2021-04-01
RECRUITING
OPTImal PHARMacological Therapy for Patients With Heart Failure: The OPTIPHARM-HF RegistryNCT06192524 · collaborator · 2022-07-18
UNKNOWN
Prognostic and Clinical Impact of Cardiovascular Involvement in Patients With COVID-19NCT04624503 · collaborator · 2020-10-01
UNKNOWN
Atrial Fibrillation Ablation Compared to Rate Control Strategy in Patients With Impaired Left Ventricular FunctionNCT02509754 · collaborator · 2016-01-01
UNKNOWN

Sponsor roles

lead sponsor21
collaborator5

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.